David Scheer, Director at Aegerion Pharmaceuticals, Inc. (AEGR), sold 20,000 shares at $85.07 ($1.7M) on 2013-08-21, disclosed to the SEC on 2013-08-23.
Open-market sale of $1.7M AEGR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.57 | 19,600 | $1.7M | 98.0% |
| 2 | $85.07 | 400 | $34K | 2.0% |
| Total | $84.58 avg | 20,000 | $1.7M | 100% |
| Filing → |
| TNGN | BUY | 2010-04-15 | $100K | — | Filing → |